Production (Stage)
MoonLake Immunotherapeutics
MLTX
$46.88
-$1.95-3.99%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 480.13M | 448.03M | 493.92M | 519.80M | 547.05M |
| Total Receivables | 2.99M | 2.84M | 2.41M | 1.68M | 1.50M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 23.15M | 23.42M | 15.98M | 15.41M | 5.04M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 506.26M | 474.29M | 512.32M | 536.88M | 553.59M |
|
|
|||||
| Total Current Assets | 506.26M | 474.29M | 512.32M | 536.88M | 553.59M |
| Net Property, Plant & Equipment | 3.30M | 3.64M | 3.83M | 3.87M | 4.21M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.70M | -- | 2.06M | 4.13M | 6.32M |
| Total Assets | 511.26M | 477.93M | 518.21M | 544.88M | 564.12M |
|
|
|||||
| Total Accounts Payable | 14.00K | 221.50K | 141.40K | 176.40K | 204.00K |
| Total Accrued Expenses | 20.30M | 20.23M | 18.01M | 9.95M | 6.36M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.43M | 1.37M | 1.44M | 1.32M | 1.30M |
| Total Finance Division Other Current Liabilities | 2.23M | 642.10K | 484.50K | 829.20K | 1.05M |
| Total Other Current Liabilities | 2.23M | 642.10K | 484.50K | 829.20K | 1.05M |
| Total Current Liabilities | 23.98M | 22.46M | 20.08M | 12.28M | 8.91M |
|
|
|||||
| Total Current Liabilities | 23.98M | 22.46M | 20.08M | 12.28M | 8.91M |
| Long-Term Debt | 73.02M | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.14M | 1.46M | 1.94M | 2.02M | 2.36M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 536.00K | 620.70K | 695.00K | 541.90K | 462.70K |
| Total Liabilities | 98.68M | 24.54M | 22.71M | 14.85M | 11.73M |
|
|
|||||
| Common Stock & APIC | 680.67M | 677.42M | 675.35M | 672.01M | 670.19M |
| Retained Earnings | -275.54M | -235.59M | -189.99M | -154.60M | -130.33M |
| Treasury Stock & Other | 2.39M | 5.00M | 2.83M | 3.26M | 2.69M |
| Total Common Equity | 407.52M | 446.83M | 488.20M | 520.66M | 542.55M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 407.52M | 446.83M | 488.20M | 520.66M | 542.55M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 5.06M | 6.57M | 7.31M | 9.37M | 9.83M |
| Total Equity | 412.58M | 453.39M | 495.50M | 530.03M | 552.39M |
|
|
|||||